Evidence labels
Every item is marked as peer reviewed, preprint, clinical trial, regulatory, company PR, news, social, or anecdotal.
Evidence model
Built to separate hope from proof.
Cure news has to be handled carefully. Type1Cure ranks items by evidence class, patient relevance, novelty, and actionability, then sends high-risk claims through human review.
The trust controls behind every label
Every research item that reaches a reader has passed through these layers. They are what keep sponsorship, hype, and anecdote from distorting the signal.
Medical guardrails
No miracle language, no supplement hype, no diagnosis advice, and no pay-to-rank editorial placement.
Idempotent ingestion
Source pulls use retries, source checksums, canonical IDs, and duplicate protection before publication.
Human review
High-impact items, safety alerts, trial eligibility, and sponsor-sensitive content enter an editorial queue.